SCHEMBL10737005

SCHEMBL10737005

Cc1c(C(=O)O)oc2c(O)ccc(O)c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 4/20 0.50
GPR35 Q9HC97 1/20 0.46
HPGD P15428 4/20 0.45
KDM4E B2RXH2 4/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
EDNRA P25101 2/20 0.45
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 2/20 0.42
HTT P42858 1/20 0.42
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
KDM5A P29375 1/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MGAM O43451 1/20 0.37
MAOA P21397 1/20 0.37
CLK1 P49759 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9868477 0.84 MCL1 (0.43) MCL1GPR35HPGDKDM4EL3MBTL1
SCHEMBL3611742 0.76 MAPT (0.65) MCL1GPR35HPGDKDM4EEDNRA
SCHEMBL11014893 0.76 ESR2 (0.36) MCL1HPGDKDM4EL3MBTL1NPC1
SCHEMBL17843607 0.76 MCL1 (0.61) MCL1GPR35HPGDKDM4EL3MBTL1
SCHEMBL10743549 0.75 RAB9A (0.51) HPGDEDNRAALDH1A1NPC1MAPT
SCHEMBL73704 0.73 RAB9A (0.56) KDM4EL3MBTL1ALDH1A1HSD17B10NPC1
SCHEMBL11748571 0.68 MCL1 (0.51) MCL1GPR35HPGDKDM4EL3MBTL1
SCHEMBL10738263 0.68 KDM4E (0.47) MCL1HPGDKDM4EL3MBTL1EDNRA
SCHEMBL10459819 0.68 MCL1 (0.56) MCL1GPR35HPGDKDM4EL3MBTL1
SCHEMBL1356879 0.67 CYP1A2 (0.55) MCL1GPR35HPGDKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4663347-A ANTIINFLAMMATORY, ANTIALLERGENS, CARDIOVASCULAR MERCK FROSST CANADA, INC. (CA) 1987-05-05 US disclosed
EP-0146243-A1 Lipoxygenase inhibitors MERCK FROSST CANADA INC. (CA) 1985-06-26 EP disclosed